Scientists have developed a new type of immunotherapy that uses genetically modified natural killer (NK) cells to target and destroy cancer cells. NK cells are a type of immune...
NRCT FAIR: SCI POWER FOR FUTURE THAILAND! Date: 22-28 July 2024Venue: Thailand Science Park Convention Center Highlights of the Event: – Science for Future Thailand: Explore the latest innovations...
Thailand Hub of Talent for Cancer Immunotherapy (TTCI) Joins SITC-WIC as Official Member June 30, 2024 We are proud to announce that the Thailand Hub of Talent for Cancer...
Celebrating Excellence in Immunotherapy: Dr. Piriya Luangwattananun Honored as Young Investigator June 30, 2024 We are thrilled to announce that Dr. Piriya Luangwattananun has been awarded the prestigious Young...
Image by ChulalongkornHospital New options for cancer treatment with immunotherapy. Jun 28, 2024 The Excellence Chulalongkorn Comprehensive Cancer Center, King Chulalongkorn Memorial Hospital, and Faculty of Medicine Chulalongkorn University...
L.M.I.C. Award Winner 2024 June 20, 2024 Congratulations to Dr. Jutharaporn Petchareeboon, Assistant Professor in the Department of Systems Biosciences & Computational Medicine at Khon Kaen University’s Faculty of...
Chula is preparing to launch a CAR-T cell service to treat lymphoma later this year! June 19, 2024 Post Today follows the progress of CAR-T cell research, Chulalongkorn doctors...
Scientists have engineered immune cells to be more effective at fighting T-cell leukemia. They modified these cells to lack a protein called CD147, which altered their behavior and showed...
Effective adaptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level https://www.ttci-th.org/wp-content/uploads/2024/06/SiCORE-CIT-Journal-Club-14-Jun-2024.mp4
